Essure contraceptive device: Hazard Alert from TGA

Therapeutic Goods Administration, August 30, 2017

Consumers and health professionals are advised that Australasian Medical and Science Ltd (AMSL), in consultation with the TGA, has issued a hazard alert for Essure. AMSL is also recallingunused stock and withdrawing the device from the Australian market.

The battle over Essure

The Washington Post, Published on July 26, 2017

Nobody can say exactly how many women have had Essure implanted since the device went on the market in 2002. Bayer, which is headquartered in Germany, says that more than 750,000 devices have been sold worldwide and that sales “continue to grow.” 

In recent years, the [US] Food and Drug Administration has received more than 16,000 adverse-event reports about Essure. These are official reports about symptoms, hospitalizations or diagnoses that patients, doctors, hospitals or a device manufacturer believe are associated with a device.

“It seems every two or three years we have another controversy in women’s health,” says Steve Xu, a health-­policy researcher and Northwestern University dermatology resident.

 

Life Matters Women’s Health Series – Part 3 – Contraception

ABC Radio National, Thursday 5 June 2014 9:24AM

Guests

Alison Bean-Hodges
Manager, Gynaecology Assessment Clinic & Sexual Health Service, Women’s Health Nurse Practitioner, The Women’s
Professor Jayne Lucke
Director of the Australian Research Centre in Sex, Health & Society at La Trobe University. Honorary Professor at The University of Queensland and a member of the Steering Committee of the Australian Longitudinal Study on Women’s Health

Listen or download here